ZA954430B - Novel elastase inhibitors - Google Patents

Novel elastase inhibitors

Info

Publication number
ZA954430B
ZA954430B ZA954430A ZA954430A ZA954430B ZA 954430 B ZA954430 B ZA 954430B ZA 954430 A ZA954430 A ZA 954430A ZA 954430 A ZA954430 A ZA 954430A ZA 954430 B ZA954430 B ZA 954430B
Authority
ZA
South Africa
Prior art keywords
inhibitors
elastase inhibitors
elastase
compounds
novel elastase
Prior art date
Application number
ZA954430A
Other languages
English (en)
Inventor
William Arthur Metz Jr
Steven Lee Gallion
Joseph Paul Burkhart
Michael Richard Angelastro
Norton Paul Peet
Original Assignee
Marion Merrell Dow Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marion Merrell Dow Inc filed Critical Marion Merrell Dow Inc
Publication of ZA954430B publication Critical patent/ZA954430B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA954430A 1994-06-02 1995-05-30 Novel elastase inhibitors ZA954430B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25279994A 1994-06-02 1994-06-02

Publications (1)

Publication Number Publication Date
ZA954430B true ZA954430B (en) 1996-02-13

Family

ID=22957608

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA954430A ZA954430B (en) 1994-06-02 1995-05-30 Novel elastase inhibitors

Country Status (20)

Country Link
EP (1) EP0804465B1 (da)
JP (1) JP3623799B2 (da)
KR (1) KR100347285B1 (da)
CN (1) CN1149877A (da)
AT (1) ATE246708T1 (da)
AU (1) AU689589B2 (da)
CA (1) CA2189527C (da)
DE (1) DE69531459T2 (da)
DK (1) DK0804465T3 (da)
ES (1) ES2199992T3 (da)
FI (1) FI964781L (da)
HU (1) HU221197B1 (da)
IL (1) IL113940A (da)
NO (1) NO965097L (da)
NZ (1) NZ285565A (da)
PT (1) PT804465E (da)
SI (1) SI0804465T1 (da)
TW (1) TW403762B (da)
WO (1) WO1995033763A1 (da)
ZA (1) ZA954430B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690986B2 (en) * 1994-06-02 1998-05-07 Merrell Pharmaceuticals Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
NZ287604A (en) * 1994-06-02 1998-12-23 Merrell Pharma Inc Acylated enol derivatives as prodrugs of elastase inhibitors
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
CL2004001161A1 (es) 2003-05-21 2005-04-08 Boehringer Ingelheim Int Compuestos describe compuestos derivados de quinolina; composicion farmaceutica; y su uso para tratar una enfermedad causada por el virus de la hepatitis c.
JP4914355B2 (ja) 2004-07-20 2012-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃ型肝炎インヒビターペプチド類似体
UY29016A1 (es) 2004-07-20 2006-02-24 Boehringer Ingelheim Int Analogos de dipeptidos inhibidores de la hepatitis c
EP2027143A2 (en) 2006-05-23 2009-02-25 Irm Llc Compounds and compositions as channel activating protease inhibitors
CA2677487A1 (en) * 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
AU2020349353A1 (en) 2019-09-17 2022-04-14 Duke University Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
HUE064089T2 (hu) 2020-04-16 2024-02-28 Mereo Biopharma 4 Ltd Alvelesztat neutrofil elasztáz inhibitort alkalmazó módszerek alfa-1-antitripszin hiány által közvetített légzõszervi megbetegedés kezelésére
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
JPH06504547A (ja) * 1990-12-28 1994-05-26 ジョージア・テック・リサーチ・コーポレーション ペプチドケトアミド、ケト酸およびケトエステル
ZA926185B (en) * 1991-08-22 1993-03-01 Merrell Dow Pharma Novel orally-active elastase inhibitors.

Also Published As

Publication number Publication date
ATE246708T1 (de) 2003-08-15
IL113940A0 (en) 1995-08-31
HUT76926A (hu) 1998-01-28
AU689589B2 (en) 1998-04-02
NO965097D0 (no) 1996-11-29
DK0804465T3 (da) 2003-11-24
NO965097L (no) 1997-01-31
WO1995033763A1 (en) 1995-12-14
EP0804465A1 (en) 1997-11-05
CN1149877A (zh) 1997-05-14
HU221197B1 (en) 2002-08-28
CA2189527C (en) 2000-12-19
MX9606030A (es) 1998-05-31
DE69531459D1 (de) 2003-09-11
SI0804465T1 (en) 2003-12-31
DE69531459T2 (de) 2004-06-24
IL113940A (en) 1999-12-31
AU2470995A (en) 1996-01-04
JP3623799B2 (ja) 2005-02-23
FI964781A7 (fi) 1997-01-29
ES2199992T3 (es) 2004-03-01
TW403762B (en) 2000-09-01
KR100347285B1 (ko) 2003-01-15
JPH10500992A (ja) 1998-01-27
FI964781A0 (fi) 1996-11-29
FI964781L (fi) 1997-01-29
CA2189527A1 (en) 1995-12-14
NZ285565A (en) 1998-08-26
EP0804465B1 (en) 2003-08-06
HU9603312D0 (en) 1997-01-28
PT804465E (pt) 2003-12-31

Similar Documents

Publication Publication Date Title
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
MX9700430A (es) El uso de compuestos heterociclicos.
BG101841A (bg) Инхибитори на клетъчна адхезия
GR3034208T3 (en) Human neutrophil elastase inhibitors
CA2189526A1 (en) Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
IL138665A0 (en) Peptide factor
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
HU9603312D0 (en) Novel elastase inhibitors
EA200200306A1 (ru) Трициклические ингибиторы поли(адф-рибозо)полимераз
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
GR3018304T3 (en) Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones.
PT971922E (pt) Compostos de tetra-hidropirido
NZ330944A (en) Peptide derivatives
AP2000001760A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
DE69726743D1 (de) Peptid analoge, die einen siebengliedrigen lactamring enthalten
TR200003352T2 (tr) Yeni pentaerythrit türevleri, bunların imalatı ve kullanımları ile bunların sentezi için ara maddeler
PE61999A1 (es) Compuestos de tetrahidropiridina